BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:11 PM
 | 
Sep 06, 2012
 |  BC Extra  |  Company News

CIRM awards $63.1M for stem cell projects

The California Institute for Regenerative Medicine (CIRM) awarded $63.1 million in grants across four stem cell therapy projects, including one from StemCells Inc. (NASDAQ:STEM) to evaluate its HuCNS-SC purified human neural stem cells to treat Alzheimer's disease. StemCells will receive up to $20 million...

Read the full 201 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >